Senior Executive / Assistant Manager, Planning

The Consortium for Clinical Research and Innovation, Singapore (CRIS) brings together seven national R&D, clinical translation and service programmes to advance clinical research and innovation for Singapore and establish important capabilities for a future‑ready healthcare system. The Business Entities under CRIS include:

• Singapore Clinical Research Institute (SCRI)
• Advanced Cell Therapy and Research Institute, Singapore (ACTRIS)
• Cardiovascular Disease National Collaborative Enterprise (CADENCE)
• Singapore Medical Foundation AI Model Programme (SIMFONI)

The Consortium for Clinical Research and Innovation Singapore (CRIS), a wholly owned subsidiary of MOH Holdings, was established in 2020 with the goal of strengthening synergies and promulgating strategies for national‑level clinical research and translation programmes under the stewardship of the Singapore Ministry of Health.

Toge...